Pfiz­er's dig­i­tal ther­a­peu­tics part­ner is back, this time in a new col­lab with Eli Lil­ly

On the heels of a com­mer­cial launch with Pfiz­er, an Ice­landic dig­i­tal ther­a­peu­tics biotech is back with an­oth­er Big Phar­ma col­lab­o­ra­tion.

Side­kick Health, less than a month af­ter an­nounc­ing a deal with Pfiz­er for atopic der­mati­tis, re­vealed Thurs­day it’s adding an­oth­er dig­i­tal ther­a­peu­tics project to its ar­se­nal in con­junc­tion with a Big Phar­ma: Eli Lil­ly, for pa­tients with breast can­cer. Pfiz­er and Side­kick had re­cent­ly launched their fourth of five planned dig­i­tal ther­a­peu­tics prod­ucts af­ter al­ready start­ing pro­grams in ul­cer­a­tive col­i­tis, Crohn’s dis­ease and rheuma­toid arthri­tis.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER